Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Katelyn, Rowland"'
2
Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry
Autor: April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Amanda Teeple, Jonathan P. Uy, Mobolaji Olurinde, Katelyn Rowland, Lin Guo, Ying Shan, Kristina Callis Duffin
Publikováno v: Dermatology and Therapy. 13:487-504
In clinical trials, treatment with the interleukin-23 inhibitor guselkumab was associated with significantly improved disease severity and patient-reported outcome measures (PROMs) among patients with moderate-to-severe plaque psoriasis. However, lim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d81782ffe2fa244ee48192f520a39ac4
https://doi.org/10.1007/s13555-022-00865-0
Zobrazit plný text záznamu
3
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure
Autor: Mark G Lebwohl, Joseph F Merola, Katelyn Rowland, Megan Miller, Ya-Wen Yang, Jenny Yu, Yin You, Daphne Chan, Diamant Thaçi, Richard G Langley
Publikováno v: British Journal of Dermatology.
Background Guselkumab has demonstrated favourable safety and efficacy across individual clinical studies in adults with moderate-to-severe plaque psoriasis. Objectives To evaluate the safety of guselkumab in patients with psoriasis using pooled data
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eb9073ee9f1f247956c7a75cbbee18ca
https://doi.org/10.1093/bjd/ljad115
Zobrazit plný text záznamu
5
E088 Safety of guselkumab in patients with psoriatic disease: an integrated analysis of 11 Phase 2 and 3 clinical studies in psoriasis and psoriatic arthritis
Autor: Bruce Strober, Laura Coates, Jenny Yu, Katelyn Rowland, Evan Leibowitz, Megan Miller, Alexa Kollmeier, Shu Li, Yanli Wang, Daphne Chan, Soumya Chakravarty, Ya-Wen Yang, May Shawi, Mark Lebwohl, Proton Rahman
Publikováno v: Rheumatology. 62
Background/Aims Guselkumab is a monoclonal antibody approved to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis (PsA). In this analysis, safety data from 11 Phase 2/3 studies of guselkumab were pooled to evaluate guselkumab s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::25f65602d000d8e5855396fb59f48399
https://doi.org/10.1093/rheumatology/kead104.337
Zobrazit plný text záznamu
6
Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database
Autor: Timothy, Fitzgerald, Aimee M, Near, Hyunchung, Kim, Amanda, Teeple, Mobolaji, Olurinde, Katelyn, Rowland
Publikováno v: Dermatology and Therapy. 12:741-752
Biologics have expanded the treatment options in the management of patients with moderate-to-severe psoriasis. The objective of this study was to describe patient characteristics and previous treatments in psoriasis patients newly treated with guselk
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdafaf5b84d446a9a266ba08da8f1510
https://doi.org/10.1007/s13555-022-00691-4
Zobrazit plný text záznamu
7
Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry
Autor: Timothy Fitzgerald, Jessica A. Walsh, Kristina Callis Duffin, Katelyn Rowland, Wendi Malley, Joseph F. Merola, Robert R. McLean, Amanda Teeple, Angel Cronin, Soumya D. Chakravarty, Abby S. Van Voorhees, Jonathan Uy
Publikováno v: Dermatology and Therapy
Introduction Guselkumab is approved for the treatment of both moderate-to-severe plaque psoriasis and active psoriatic arthritis (PsA) in the USA. However, little is known about patients initiating guselkumab in a real-world setting. The objective of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32fbe07c244d3f050b7b7a9f6669b9c8
https://doi.org/10.1007/s13555-021-00637-2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje